Prevalence of oral conditions among methamphetamine users: NHANES 2009-2014.


Journal

Journal of public health dentistry
ISSN: 1752-7325
Titre abrégé: J Public Health Dent
Pays: United States
ID NLM: 0014207

Informations de publication

Date de publication:
12 2021
Historique:
revised: 08 06 2020
received: 04 02 2020
accepted: 02 07 2020
pubmed: 20 8 2020
medline: 16 4 2021
entrez: 20 8 2020
Statut: ppublish

Résumé

Methamphetamine (MA) is a widely used illicit drug and a nationwide public health concern. Although dental complications are consistently reported among MA users, yet limited nationally representative studies on the associations between MA use and oral health currently exist. Using the National Health and Nutrition Examination Survey 2009-2014, we analyzed 8,762 respondents aged 30-64 years who had completed a periodontal examination. MA use was self-reported; periodontitis, untreated caries, and missing teeth were assessed by calibrated dentists. Descriptive statistics as well as multivariable regression analyses were performed. Data were weighted to yield representative estimates of the US adult population. Overall 7.8 percent of US adults aged ≥30 years had ever used MA. Ever-use prevalence was higher among males, whites, and individuals below the federal poverty level. Established MA users had a higher prevalence of untreated dental caries (36.6 percent), any periodontitis (54.8 percent), and severe periodontitis (12.2 percent) than those who had never used MA. The prevalence of any periodontitis was higher among current MA users (PR: 1.31; 95% CI: 1.05-1.62) than those who never used MA. Prevalence of untreated dental caries was higher among current MA users (PR: 1.53; 95% CI: 1.10-2.13) and established users (PR: 1.21; 95% CI: 1.02-1.48) than never users. Taking MA orally and/or through injection was associated with higher odds of severe periodontitis than orally only (AOR: 3.72; CI: 1.79-7.75). MA users had a higher prevalence of periodontitis and dental caries. Continued research assessing the relationship between MA use and oral health can inform clinical interventions and management of dental diseases in MA users.

Identifiants

pubmed: 32812220
doi: 10.1111/jphd.12389
doi:

Substances chimiques

Methamphetamine 44RAL3456C

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

21-28

Informations de copyright

© 2020 American Association of Public Health Dentistry.

Références

Key substance use and mental health indicators in the United States: Results from the 2018 National Survey on Drug Use and Health. [Internet] [cited Aug 2019]. Substance Abuse and Mental Health Services Administration; [accessed 2019 Dec 23]. Available from: https://www.samhsa.gov/data/sites/default/files/cbhsqreports/NSDUHNationalFindingsReport2018/NSDUHNationalFindingsReport2018.pdf
Key substance use and mental health indicators in the United States: Results from the 2017 National Survey on Drug Use and Health. [Internet] [cited Sep 2018]. Substance Abuse and Mental Health Services Administration; [accessed 2019 Dec 23]. Available from: https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHFFR2017/NSDUHFFR2017.pdf
Harro J. Neuropsychiatric adverse effects of amphetamine and methamphetamine. Int Rev Neurobiol. 2015;120:179-204.
Darke S, Kaye S, McKetin R, Duflou J. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev. 2008;27(3):253-62.
Niemi-Pynttäri JA, Sund R, Putkonen H, Vorma H, Wahlbeck K, Pirkola SP. Substance-induced psychoses converting into schizophrenia: a register-based study of 18,478 Finnish inpatient cases. J Clin Psychiatr. 2013;74(1):e94-9.
McKetin R, Lubman DI, Najman JM, Dawe S, Butterworth P, Baker AL. Does methamphetamine use increase violent behaviour? Evidence from a prospective longitudinal study. Addiction. 2014;109(5):798-806.
Kittirattanapaiboon P, Mahatnirunkul S, Booncharoen H, Thummawomg P, Dumrongchai U, Chutha W. Long-term outcomes in methamphetamine psychosis patients after first hospitalisation. Drug Alcohol Rev. 2010;29(4):456-61.
Cruickshank CC, Dyer KR. A review of the clinical pharmacology of methamphetamine. Addiction. 2009;104(7):1085-99.
Rawson RA, Gonzales R, Marinelli-Casey P, Ang A. Methamphetamine dependence: a closer look at treatment response and clinical characteristics associated with route of administration in outpatient treatment. Am J Addic. 2007;16(4):291-9.
Brown C, Krishnan S, Hursh K, Yu M, Johnson P, Page K, Shiboski CH. Dental disease prevalence among methamphetamine and heroin users in an urban setting: a pilot study. J Am Dent Assoc. 2012;143(9):992-1001.
Ye T, Sun D, Dong G, Xu G, Wang L, Du J. The effect of methamphetamine abuse on dental caries and periodontal diseases in an eastern China city. BMC Oral Health. 2018;18(1):8.
Rommel N, Rohleder NH, Wagenpfeil S, Härtel-Petri R, Jacob F, Wolff KD, Kesting MR. The impact of the new scene drug “crystal meth” on oral health: a case-control study. Clin Oral Investig. 2016;20(3):469-75.
Shetty V, Harrell L, Murphy DA, Vitero S, Gutierrez A, Belin TR, Dye BA, Spolsky VW. Dental disease patterns in methamphetamine users: findings in a large urban sample. J Am Dent Assoc. 2015;146(12):875-85.
Marshall BD, Werb D. Health outcomes associated with methamphetamine use among young people: a systematic review. Addiction. 2010;105(6):991-1002.
Kim RS, Weinberger AH, Chander G, Sulkowski MS, Norton B, Shuter J. Cigarette smoking in persons living with hepatitis C: the National Health and nutrition examination survey (NHANES), 1999-2014. Am J Med. 2018;131(6):669-75.
Eke PI, Page RC, Wei L, Thornton-Evans G, Genco RJ. Update of the case definitions for population-based surveillance of periodontitis. J Periodontol. 2012;83(12):1449-54.
Mumcu E, Beklen A. The effect of smoking on the marginal bone loss around implant-supported prostheses. Tob Induc Dis. 2019;17:43.
Jiang X, Jiang X, Wang Y, Huang R. Correlation between tobacco smoking and dental caries: a systematic review and meta-analysis. Tob Induc Dis. 2019;17:34.
Morio KA, Marshall TA, Qian F, Morgan TA. Comparing diet, oral hygiene and caries status of adult methamphetamine users and nonusers: a pilot study. J Am Dent Assoc. 2008;139(2):171-6.
Shetty V, Harrell L, Clague J, Murphy DA, Dye BA, Belin TR. Methamphetamine users have increased dental disease: a propensity score analysis. J Dent Res. 2016;95(7):814-21.
Saini TS, Edwards PC, Kimmes NS, Carroll LR, Shaner JW, Dowd FJ. Etiology of xerostomia and dental caries among methamphetamine abusers. Oral Health Prev Dent. 2005;3(3):189-95.
Eke PI, Thornton-Evans GO, Wei L, Borgnakke WS, Dye BA, Genco RJ. Periodontitis in US adults: national health and nutrition examination survey 2009-2014. J Am Dent Assoc. 2018;149(7):576-88.
Spolsky VW, Clague J, Murphy DA, Vitero S, Dye BA, Belin TR, Shetty V. Periodontal status of current methamphetamine users. J Am Dent Assoc. 2018;149(3):174-83.
Shetty V, Mooney LJ, Zigler CM, Belin TR, Murphy D, Rawson R. The relationship between methamphetamine use and increased dental disease. J Am Dent Assoc. 2010;141(3):307-18.

Auteurs

Fahad Hegazi (F)

Preventive Dental Sciences, Imam Abdulrahman Bin Faisal University, College of Dentistry, Dammam, Saudi Arabia.

Hesham Alhazmi (H)

Preventive Dentistry, Umm Al-Qura University, Makkah, Saudi Arabia.

Abeer Abdullah (A)

Preventive Dental Science, King Abdulaziz University, Riyadh, Saudi Arabia.

Nora Alamer (N)

Periodontics and Community Dentistry, King Saud University, Riyadh, Saudi Arabia.

Jevae Nelson (J)

Oral Health Policy and Epidemiology, Harvard School of Dental Medicine, Boston, MA, USA.

Muath Aldosari (M)

Oral Health Policy and Epidemiology, Harvard School of Dental Medicine, Boston, MA, USA.

Nailah Tillman (N)

Oral Health Policy and Epidemiology, Harvard School of Dental Medicine, Boston, MA, USA.

Dania Bahdila (D)

Preventive Dental Science, King Abdulaziz University, Riyadh, Saudi Arabia.

Satomi Odani (S)

University of Crete School of Medicine, Crete, Greece.

Israel Agaku (I)

Oral Health Policy and Epidemiology, Harvard School of Dental Medicine, Boston, MA, USA.

Constantine Vardavas (C)

Oral Health Policy and Epidemiology, Harvard School of Dental Medicine, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH